Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Chemotherapy as First Line Treatment of Unresectable Gastroesophageal Junction or Gastric Adenocarcinoma
Conditions: Gastric Cancer; GastroEsophageal Cancer Interventions: Device: NovoTTF-100L(P); Drug: Oxaliplatin; Drug: Capecitabine; Drug: Trastuzumab Sponsors: NovoCure GmbH; Zai Lab (Shanghai) Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Herceptin | Research | Xeloda